Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: Value of gray-scale and Doppler US in 100 patients

Radiology

Volumn 204, Issue 2, 1997, Pages 545-552

  Lassau, Nathalie ^a   Leclère, Jérome ^a   Auperin, Anne ^a   Bourhis, Jean H ^a   Hartmann, Olivier ^a   Valteau Couanet, Dominique ^a   Benhamou, Ellen ^a   Bosq, Jacques ^a   Ibrahim, Amad ^a   Girinski, Théo ^a   Pico, José L ^a   Roche, Alain ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Hepatic arteries, stenosis or obstruction; Hepatic arteries, US; Liver, US; Portal vein, stenosis or obstruction; Portal vein, US

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DOPPLER FLOWMETRY; FEMALE; HUMAN; LIVER INJURY; LIVER VEIN; LIVER VEIN OBSTRUCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VEIN OCCLUSION;

EID: 1842405940     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.204.2.9240551     Document Type: Article

References (48)

1. McDonald GB, Hinds MS, Fisher LD, et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118:255-267.
2. Bearman SI. The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 1995; 85:3005-3020.
3. McDonald GB, Sharma P, Matthews DE, Shulman HM. Veno-occlusive disease of the liver after bone marrow transplantation: diagnosis, incidence and factors. Hepatology 1984; 4:116-122.
4. Shulman HM, McDonald GB. Transvenous liver biopsies and pressure measurements in bone marrow transplant recipients (abstr). Hepatology 1992; 16:148.
5. Carreras E, Granena A, Navasa M, et al. Transjugular liver biopsy in BMT. Bone Marrow Transplant 1993; 11:21-26.
6. Jones RJ, Lee KSK, Beschorner WE, et al. Veno-occlusive disease of the liver following bone marrow transplantation. Transplantation 1987; 44:778-783.
7. Meresse V, Hartmann O, Vassal G, et al. Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children. Bone Marrow Transplant 1992; 10:135-141.
8. Brugieres L, Hartmann O, Benhamou E, et al. Veno-occlusive disease of the liver following high-dose chemotherapy and autologous bone marrow transplantation in children with solid tumors: incidence, clinical course and outcome. Bone Marrow Transplant 1988; 3:53-58.
9. Bearman SI, Anderson GL, Mori M, Hinds MS, Shulman HM, McDonald GB. Veno-occlusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation. J Clin Oncol 1993; 11:1729-1736.
10. Rollins BJ. Hepatic veno-occlusive disease. Am J Med 1986; 81:197-206.
11. McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED. The clinical course of 53 patients with veno-occlusive disease of the liver after marrow transplantation. Transplantation 1985; 39:603-608.
12. Atkinson K, Biggs J, Noble G, Ashby M, Concannon A, Dodds A. Preparative regimens for marrow transplantation containing busulfan are associated with hemorrhagic cystitis and hepatic veno-occlusive disease but a short duration of leucopenia and little oro-pharyngeal mucositis. Bone Marrow Transplant 1987; 2:385-394.
13. Baume D, Cosset JM, Pico JL, et al. Maladie veno-occlusive du foie après greffe de moelle osseuse: intérêt possible du fractionnement de l'irradiation totale (letter). Presse Med 1987; 16:1759.
14. Locasciulli A, Bacigalupo A, Albert A, et al. Predictability following allogeneic bone marrow transplantation. Transplantation 1989; 48:68-72.
15. Radich JP, Sanders J, Buckner CD, et al. Second allogeneic bone marrow transplants for patients relapsing after initial transplant by TBI containing regimens (abstr). Blood 1981; 78:241a.
16. Dulley FL, Kaufer EJ, Appelbaum FR. Venoocclusive disease of the liver after chemoradiotherapy and autologous bone marrow transplantation. Transplantation 1987; 43:870-873.
17. Attal M, Huguet F, Rubie H, et al. Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial. Blood 1992; 79: 2834-2840.
18. Shulman HM, Gown AM, Nugent DJ. Hepatic veno-occlusive disease after bone marrow transplantation. Am J Pathol 1987; 127:549-556.
19. Rowe JM. Hepatic veno-occlusive disease in bone marrow transplantation. Bone Marrow Transplant 1993; 11:471-472.
20. Teefey SA, Brink JA, Borson RA, Middleton WD. Diagnosis of venoocclusive disease of the liver after bone marrow transplantation: value of duplex sonography. AJR 1995; 164:1397-1401.
21. Hommeyer SC, Teefey SA, Jacobson AF, et al. Venoocclusive disease of the liver: prospective study of US evaluation. Radiology 1992; 184:683-686.
22. Matsuishi E, Anzai K, Dohmen K, et al. Sonographic diagnosis of venoocclusive disease of the liver and Danazol therapy of autoimmune thrombocytopenia in an autologous marrow transplant patient. J Clin Oncol 1990; 20:188-192.
23. Nelson RC, Lovett K, Chezmar JL, et al. Comparison of pulsed Doppler sonography and angiography in patients with portal hypertension. AJR 1987; 149:77-81.
24. Lafortune M. Le Doppler dans l'investigation du foie. In: Mathieu D, ed. Imagerie médicale du foie et des voies biliaires. Paris, France: Vigot, 1988; 30.
25. Moriyasu F, Nishida O, Ban N, et al. "Congestion index" of the portal vein. AJR 1986; 146:735-739.
26. Dauzat M, Lafortune M. Foie et Doppler: vers une meilleure compréhension de l'hémodynamique hépatique? Rev Im Med 1994; 6:3-13.
27. Zoli M, Marchesini G, Cordiani MR, et al. Echo Doppler measurement of splanchnic blood flow in control and cirrhotic subjects. JCU 1986; 14:429-435.
28. Patriquin H, Lafortune M, Burns P, Dauzat M. Duplex Doppler examination in portal hypertension: technique and anatomy. AJR 1987; 149:71-76.
29. Alpern MB, Rubin JM, Williams DM, Capek P. Porta hepatis: duplex Doppler US with angiographic correlation. Radiology 1987; 162:53-56.
30. Lafortune M, Constantin A, Breton G, Legare AG, Lavoie P. The recanalized umbilical vein in portal hypertension: a myth. AJR 1985; 144:549-553.
31. Mostbeck GH, Wittich GR, Herold C, et al. Hemodynamic significance of the paraumbilical vein in portal hypertension: assessment with duplex US. Radiology 1989; 170: 339-342.
32. Gibson RN, Gibson PR, Donlan JD, Clunie DA. Identification of a patent paraumbilical vein by using Doppler sonography: importance in the diagnosis of portal hypertension. AJR 1989; 153:513-516.
33. Saddekni S, Hutchinson DE, Coopurberg PL. The sonographically patent umbilical vein in portal hypertension. Radiology 1982; 145:441-443.
34. Salmi A, Paterlini A. Sonographic patent umbilical vein: lack of specificity for portal hypertension. Am J Gastroenterol 1986; 81: 556-558.
35. Kriegshauser JS, Charboneau JW, Letendre L. Hepatic venoocclusive disease after bone-marrow transplantation: diagnosis with duplex sonography. AJR 1988; 150: 289-290.
36. Brown BP, Abu-Yousef M, LaBrecque D, Gingrich R. Doppler sonography: a non-invasive method for evaluation of hepatic veno-occlusive disease. AJR 1990; 154:721-724.
37. Herbetko J, Grigg AP, Buckley AR, Phillips GL. Venoocclusive liver disease after bone marrow transplantation: findings at duplex sonography. AJR 1992; 158:1001-1005.
38. Shulman HM, Hinterberger W. Hepatic veno-occlusive disease, liver toxicity syndrome after bone marrow transplantation. Bone Marrow Transplant 1992; 10:197-214.
39. Carreras E, Granena A, Rozman C. Hepatic veno-occlusive disease after bone marrow transplant. Blood Rev 1993; 7:43-51.
40. McDonald GB, Hinds M, Fisher L, Schoch HG. Liver toxicity following cytoreductive therapy for bone marrow transplantation: risk factors, incidence, and outcome (abstr). Hepatology 1991; 14:162a.
41. Ibrahim A, Pico JL, Maraninchi D, et al. Hepatic veno-occlusive disease following bone marrow transplantation treated by prostaglandin E1 (abstr). Bone Marrow Transplant 1991; 7:53a.
42. Gluckman E, Jolivet I, Scrobohaci ML, et al. Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation. Br J Haematol 1990; 74: 277-281.
43. Ringden O, Wennberg L, Ericzon BG, et al. Alteplase for hepatic veno-occlusive disease after bone marrow transplantation. Lancet 1992; 340:546-547.
44. Eisenhauer T, Hartmann H, Rumpf KW, Helmchen U, Scheler F, Creutzfeldt W. Favorable outcome of hepatic veno-occlusive disease in a renal transplant patient receiving azathioprine, treated by portocaval shunt: report of a case and review of the literature. Digestion 1984; 30:185-190.
45. Murray JA, Labrecque DR, Gingrich RD, Pringle KC, Mitros FA. Successful treatment of hepatic venocclusive disease in a bone marrow transplant patient with side-to-side portocaval shunt. Gastroenterology 1987; 92:1073-1077.
46. Gottesman L, Turnbull AD, O'Reilly RJ. Surgical implications of hepatic venocclusive disease in a bone marrow transplantation. J Surg Oncol 1988; 37:113-115.
47. Rapoport AP, Doyle HR, Starzl T, Rowe JM, Doeblin T, Di Persio JF. Orthotopic liver transplantion for life-threatening veno-occlusive disease of the liver after allogenic bone marrow transplant. Bone Marrow Transplant 1991; 8:421-424.
48. Nimer SD, Milewicz AL, Champlin RE, Busuttil RW. Successful treatment of hepatic venoocclusive disease in a bone marrow transplant patient with orthotopic liver transplantation. Transplantation 1990; 49: 819-821.